These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21518979)
1. Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins? Liao JK Circulation; 2011 May; 123(18):1925-8. PubMed ID: 21518979 [No Abstract] [Full Text] [Related]
2. Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. Seiki S; Frishman WH Cardiol Rev; 2009; 17(2):70-6. PubMed ID: 19367148 [TBL] [Abstract][Full Text] [Related]
3. Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. Stein EA; Bays H; O'Brien D; Pedicano J; Piper E; Spezzi A Circulation; 2011 May; 123(18):1974-85. PubMed ID: 21518985 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs. Nishimoto T; Ishikawa E; Anayama H; Hamajyo H; Nagai H; Hirakata M; Tozawa R Toxicol Appl Pharmacol; 2007 Aug; 223(1):39-45. PubMed ID: 17599378 [TBL] [Abstract][Full Text] [Related]